Evidence map›Paper›PMID 38966036›Full record

ArticleActa clinica Croatica2023

DIFFERENT APPROACHES TO MANAGING UROLITHIASIS IN KIDNEY TRANSPLANT PATIENTS - A CASE REPORT.

Ivana Peko, Josip Španjol, Romano Oguić, Antun Gršković, Dražen Rahelić, Nino Rubinić, Mauro Materljan, Ante Jakšić, Dean Markić

Abstract readCase Reports
In one paragraph

Article in Acta clinica Croatica, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Factors associated withFrontiers in medicine · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ivana PekoUniversity of Rijeka, School of Medicine, Rijeka, Croatia.
Josip ŠpanjolUniversity of Rijeka, School of Medicine, Rijeka, Croatia.
Romano OguićUniversity of Rijeka, School of Medicine, Rijeka, Croatia.
Antun GrškovićUniversity of Rijeka, School of Medicine, Rijeka, Croatia.
Dražen RahelićDepartment of Urology, Rijeka University Hospital Center, Rijeka, Croatia.
Nino RubinićDepartment of Urology, Rijeka University Hospital Center, Rijeka, Croatia.
Mauro MaterljanDepartment of Urology, Rijeka University Hospital Center, Rijeka, Croatia.
Ante JakšićDepartment of Urology, Rijeka University Hospital Center, Rijeka, Croatia.
Dean MarkićUniversity of Rijeka, School of Medicine, Rijeka, Croatia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Urolithiasis is a rare urologic complication after kidney transplantation, and its diagnosis and treatment can be challenging for clinicians. In our 52-year-old male patient, graft hydronephrosis was found six months after transplantation. The patient had recurrent urinary tract infections followed by macrohematuria and an increase in creatinine levels. Computerized tomography revealed a 13-mm diameter stone in the ureter of the transplanted kidney as the cause of obstruction. Percutaneous nephrostomy was placed in the graft to solve the obstruction. Initial endoscopic treatment with a retrograde approach failed. An antegrade approach through a previously placed nephrostomy was not successful either. By a repeated retrograde approach, laser lithotripsy was performed successfully. The patient has been monitored for six months and has stable graft function without hydronephrosis or stones. As in our patient's case, the diagnosis and treatment of urolithiasis in kidney transplant patients is challenging, and minimally invasive procedures are the treatment of choice.

Indexed as

Kidney TransplantationHumansLithotripsy, LaserMaleMiddle AgedNephrostomy, PercutaneousUrolithiasisKidney transplantationLaser lithotripsyUreterolithiasisUreteroscopy

Identifiers

PMID38966036
PMCPMC11221224

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.